Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis

被引：0
作者：
Theodoros Karampitsakos
Apostolos Galaris
Serafeim Chrysikos
Ourania Papaioannou
Ioannis Vamvakaris
Ilianna Barbayianni
Paraskevi Kanellopoulou
Sofia Grammenoudi
Nektarios Anagnostopoulos
Grigoris Stratakos
Matthaios Katsaras
Fotios Sampsonas
Katerina Dimakou
Effrosyni D. Manali
Spyridon Papiris
Bochra Tourki
Brenda M Juan-Guardela
Petros Bakakos
Demosthenes Bouros
Jose D Herazo-Maya
Vassilis Aidinis
Argyris Tzouvelekis
机构：
[1] University Hospital of Patras,Department of Respiratory Medicine
[2] University of South Florida,Ubben Center and Laboratory for Pulmonary Fibrosis Research, Morsani College of Medicine
[3] Institute of Bio- Innovation,5th Department of Pneumonology
[4] Biomedical Sciences Research Center Alexander Fleming,Department of Pathology
[5] Hospital for Thoracic Diseases,First Academic Department of Pneumonology, “SOTIRIA”, Medical School
[6] “SOTIRIA”,2nd Pulmonary Medicine Department, Athens Medical School
[7] Hospital for Thoracic Diseases,undefined
[8] “SOTIRIA”,undefined
[9] Hospital for Thoracic Diseases,undefined
[10] National and Kapodistrian University of Athens,undefined
[11] “ATTIKON” University Hospital,undefined
[12] National and Kapodistrian University of Athens,undefined
来源：
Respiratory Research | / 24卷
关键词：
Idiopathic pulmonary fibrosis; Mediastinal lymph nodes; Lung cancer; PD-1/PD-L1 axis; Pembrolizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer
    Huang, Di
    Zhang, Fan
    Tao, Haitao
    Zhang, Sujie
    Ma, Junxun
    Wang, Jinliang
    Liu, Zhefeng
    Cui, Pengfei
    Chen, Shixue
    Huang, Ziwei
    Wu, Zhaozhen
    Zhao, Lei
    Hu, Yi
    TARGETED ONCOLOGY, 2020, 15 (01) : 93 - 100
  • [32] Determining the optimal PD-1/PD-L1 inhibitors for the first-line treatment of non-small-cell lung cancer with high-level PD-L1 expression in China
    Teng, Meng-Meng
    Chen, Si-Ying
    Yang, Bo
    Wang, Yan
    Han, Rui-Ying
    An, Meng-Na
    Dong, Ya-lin
    You, Hai-Sheng
    CANCER MEDICINE, 2021, 10 (18): : 6344 - 6353
  • [33] CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma
    Hu, Zhang-Wei
    Sun, Wei
    Wen, Yi-Hui
    Ma, Ren-Qiang
    Chen, Lin
    Chen, Wen-Qing
    Lei, Wen-Bin
    Wen, Wei-Ping
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer
    Mussafi, Ofek
    Mei, Jie
    Mao, Wenjun
    Wan, Yuan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer
    Sheffield, Brandon S.
    Fulton, Regan
    Kalloger, Steve E.
    Milne, Katy
    Geller, Georgia
    Jones, Martin
    Jacquemont, Celine
    Zachara, Susanna
    Zhao, Eric
    Pleasance, Erin
    Laskin, Janessa
    Jones, Steven J. M.
    Marra, Marco A.
    Yip, Stephen
    Nelson, Brad H.
    Gown, Allen M.
    Ho, Cheryl
    Ionescu, Diana N.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2016, 64 (10) : 587 - 600
  • [36] Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer
    Sun, W.
    Ma, K.
    Wang, X.
    Liu, Y.
    He, H.
    Guo, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1736 - S1736
  • [37] Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines
    Xu, Shiting
    Miura, Keita
    Shukuya, Takehito
    Harada, Sonoko
    Fujioka, Masahiro
    Winardi, Wira
    Shimamura, Shoko
    Kurokawa, Kana
    Sumiyoshi, Issei
    Miyawaki, Taichi
    Asao, Tetsuhiko
    Mitsuishi, Yoichiro
    Tajima, Ken
    Takahashi, Fumiyuki
    Hayashi, Takuo
    Harada, Norihiro
    Takahashi, Kazuhisa
    CANCERS, 2023, 15 (04)
  • [38] PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials
    Durgesh Wankhede
    Paul Hofman
    Sandeep Grover
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2179 - 2189
  • [39] Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases
    Keller, Manuel D.
    Neppl, Christina
    Irmak, Yasin
    Hall, Sean R.
    Schmid, Ralph A.
    Langer, Rupert
    Berezowska, Sabina
    MODERN PATHOLOGY, 2018, 31 (01) : 101 - 110
  • [40] Effect of PD-L1 Expression for the PD-1/L1 Inhibitors on Non-small Cell Lung Cancer: A Meta-analysis Based on Randomised Controlled Trials
    Xu, Z.
    Lang, J.
    Fu, R.
    Yang, L.
    Chen, Y. Xin
    Ren, W.
    Lu, Y.
    Qiu, X.
    Gu, Q.
    CLINICAL ONCOLOGY, 2023, 35 (10) : 640 - 651
12345